ZA855476B - Compounds for site-enhanced delivery of radionuclides and uses thereof - Google Patents

Compounds for site-enhanced delivery of radionuclides and uses thereof

Info

Publication number
ZA855476B
ZA855476B ZA855476A ZA855476A ZA855476B ZA 855476 B ZA855476 B ZA 855476B ZA 855476 A ZA855476 A ZA 855476A ZA 855476 A ZA855476 A ZA 855476A ZA 855476 B ZA855476 B ZA 855476B
Authority
ZA
South Africa
Prior art keywords
radionuclides
site
compounds
enhanced delivery
enhanced
Prior art date
Application number
ZA855476A
Other languages
English (en)
Inventor
Nicholas S Bodor
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of ZA855476B publication Critical patent/ZA855476B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
ZA855476A 1984-07-19 1985-07-19 Compounds for site-enhanced delivery of radionuclides and uses thereof ZA855476B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63231484A 1984-07-19 1984-07-19

Publications (1)

Publication Number Publication Date
ZA855476B true ZA855476B (en) 1987-03-25

Family

ID=24535023

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855476A ZA855476B (en) 1984-07-19 1985-07-19 Compounds for site-enhanced delivery of radionuclides and uses thereof

Country Status (13)

Country Link
EP (1) EP0187832A1 (mo)
JP (1) JPS61106556A (mo)
KR (1) KR900007514B1 (mo)
AU (1) AU4635885A (mo)
CA (1) CA1267899A (mo)
DK (1) DK124786A (mo)
ES (1) ES8704900A1 (mo)
FI (1) FI861118A0 (mo)
GR (1) GR851792B (mo)
NO (1) NO860981L (mo)
PT (1) PT80841B (mo)
WO (1) WO1986000898A1 (mo)
ZA (1) ZA855476B (mo)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079366A (en) * 1987-04-07 1992-01-07 University Of Florida Quarternary pyridinium salts
US4888427A (en) * 1987-04-07 1989-12-19 University Of Florida Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain
DE3879024T2 (de) * 1987-07-31 1993-10-07 Takeda Chemical Industries Ltd Pyridinium-Derivate, ihre Herstellung und Verwendung.
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
JP4677863B2 (ja) * 2005-09-05 2011-04-27 堺化学工業株式会社 チオール系光硬化性モノマーおよび光硬化型樹脂組成物
US8701166B2 (en) 2011-12-09 2014-04-15 Blackberry Limited Secure authentication
US10864279B2 (en) 2016-12-16 2020-12-15 Industrial Technology Research Institute Linker-drug and antibody-drug conjugate (ADC) employing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382795T2 (de) * 1982-05-18 1996-02-15 University Of Florida, Gainesville, Fla. Gehirnspezifische arzneimittelabgabe.

Also Published As

Publication number Publication date
ES8704900A1 (es) 1987-04-16
ES552072A0 (es) 1987-04-16
GR851792B (mo) 1985-11-26
KR860000871A (ko) 1986-02-20
JPS61106556A (ja) 1986-05-24
FI861118L (fi) 1986-03-18
PT80841A (en) 1985-08-01
CA1267899A (en) 1990-04-17
AU4635885A (en) 1986-02-25
EP0187832A1 (en) 1986-07-23
DK124786D0 (da) 1986-03-18
DK124786A (da) 1986-05-20
FI861118A7 (fi) 1986-03-18
FI861118A0 (fi) 1986-03-18
KR900007514B1 (ko) 1990-10-11
PT80841B (en) 1987-06-03
NO860981L (no) 1986-05-20
WO1986000898A1 (en) 1986-02-13

Similar Documents

Publication Publication Date Title
PH22863A (en) Pyrrolobenzimidazoles and pharmaceutical composition containing them
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
DE3565937D1 (en) Medical composition for external application
GB2153678B (en) Pharmaceutical composition
GB8414044D0 (en) Administering powdered substances
EP0173990A3 (en) External pharmaceutical composition
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
EP0163178A3 (en) Pharmaceutical composition
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
GB2155914B (en) Treatment of technetium containing solns
PH21185A (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical composition containing them
IL74149A0 (en) Ion chelators and pharmaceutical compositions containing them
GB2153677B (en) Pharmaceutical composition
DE3568578D1 (en) Beta-lactam compound and preparing thereof
GB8523490D0 (en) Medicinal composition
PH21046A (en) Imidazole derivatives and pharmaceutical composition containing said compound
AU4635885A (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
PH25904A (en) Polycyclic compounds and pharmaceutical formulations containing them
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
PH23343A (en) 8 0( acylaminoergolines and pharmaceutical compositions containing them
GB2161979B (en) Radionuclides
DE3480340D1 (en) Novel radioactive iodospiroperidol and process for its preparation
IL74168A (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
JPS57176947A (en) Composition and compound